pharmaceutical investing Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
Sun Summit Commences Drilling and Provides Exploration Update from the JD Project in BC's Toodoggone District
